Detalhe da pesquisa
1.
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting.
J Viral Hepat
; 28(3): 558-568, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306247
2.
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort.
Liver Int
; 40(4): 769-777, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31970845
3.
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C.
J Hepatol
; 70(3): 379-387, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30472321
4.
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study.
Hepatol Commun
; 6(4): 867-877, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34811949
5.
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study.
Dig Liver Dis
; 52(2): 190-198, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813755